Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Addiction (Abingdon, England)|March 31, 1998
Maternal cannabis use and birth weight: a meta-analysisD R English, G K Hulse, E Milne, et al.Australian and New Zealand Journal of Public Health|November 27, 1999
First-time hospital admissions with illicit drug problems in indigenous and non-indigenous Western Australians: an application of record linkage to public health surveillanceK M Patterson, C D Holman, D R English, et al.Addiction (Abingdon, England)|March 31, 1998
Maternal cocaine use and low birth weight newborns: a meta-analysisG K Hulse, D R English, E Milne, et al.Psychological Medicine|October 19, 2000
Suicide and attempted suicide among older adults in Western AustraliaD Lawrence, O P Almeida, G K Hulse, et al.Drug and Alcohol Dependence|June 1, 2022
A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of conceptT MacDonald, A T Gallo, G Basso-Hulse, et al.Journal of Biomedical Materials Research. Part A|December 20, 2008
Minor pathological changes are induced by naltrexone-poly(DL-lactide) implants in pregnant ratsW O Farid, D McCallum, R J Tait, et al.Addiction Biology|June 19, 2004
Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implantsG K Hulse, D E Arnold-Reed, G O'Neil, et al.Addiction Biology|June 19, 2004
Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implantsG K Hulse, D E Arnold-Reed, G O'Neil, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 13, 2005
Histological changes over time around the site of sustained release naltrexone-poly(DL-lactide) implants in humansG K Hulse, V Stalenberg, D McCallum, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 27, 2007
Blood naltrexone levels over time following naltrexone implantH T T Ngo, D E Arnold-Reed, R C Hansson, et al.Pageof 4